News

Financial calendar

Financial calendar

Financial calendar for Borgestad ASA FINANCIAL YEAR 2026 30.10.2026 - Quarterly Report - Q3 24.02.2027 - Quarterly Report - Q4 FINANCIAL YEAR 2027 20.08.2027 - Half-yearly Report 29.04.2027 - Annual Report 20.05.2027 - Annual General Meeting 21.05.2027 - Quarterly...

Interim financial report for second quarter 2026

Interim financial report for second quarter 2026

Highlights In Q2 2026, Borgestad Group delivered a result before tax of MNOK 35.9, compared to adjusted MNOK 20.9 in 2025. Höganäs Borgestad delivered a stronger Q2’26 results compared to the corresponding period in 2025, reporting revenues of MNOK 290.4 and an EBIT...

Invitation to presentation of Q2 2026 results

Invitation to presentation of Q2 2026 results

Borgestad ASA (the "Company") will release its Q2 2026 results on 14 August 2026. The report and presentation will be made available at 07:00 hours (CET) at www.borgestad.no and www.newsweb.no. In connection with the release of the Q2 results, the Company will host a...

Result of offer to buy back own shares

Result of offer to buy back own shares

Lysaker, 2 June 2026: Reference is made to the stock exchange announcement published by Borgestad ASA (the “Company”) on 27 May 2026 regarding the launch of an offer to buy back existing shares in the Company (the “Offer”), and to the announcements published on 1 June...

Status of bookbuilding

Status of bookbuilding

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. PLEASE SEE THE IMPORTANT...

Initiation of offer to buy back own shares

Initiation of offer to buy back own shares

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. PLEASE SEE THE IMPORTANT...